- A Coursera course “Drugs and the Brain” and the Nisbett et al. 2012 review were highlighted as resources that cast doubt on the idea that common genetic polymorphisms explain normal-range IQ variation.  
- The DIYbio movement was examined through Marcus Wohlsen’s free PDF “Biopunk” and a Nature Scitable blog post, with debate on whether media figures like Meredith Patterson or hardware projects like OpenPCR better shape public perception.  
- Participants dissected whether classic stimulants (methamphetamine, prescription amphetamines) or psychedelics (LSD, 25I-NBOMe, ibogaine) can be true nootropics, concluding that tolerance, sub-perceptual dosing, and weak psychometric tests obscure any real performance gains.  
- A central argument pitted “energy-metabolism” claims (higher cerebral glucose use = enhancement) against the counter-evidence that reduced metabolic demand often accompanies better task performance, underscoring the need for circuit-level metrics over folk-psychology labels.  
- Alexander Shulgin’s two-book catalog of phenethylamines and tryptamines was proposed as a model “design-a-better-nootropic” program, though skeptics noted that prolific chemical authorship is not necessarily drug-enabled and listed other high-output chemists as counter-examples.  
- nmz787 outlined plans to acquire a DNA synthesizer to express enzymes for small-molecule production, advocating in-vitro or model-organism screening instead of self-experimentation to avoid addiction and toxicity.  
- kanzure reported successful tests of android-x86-4.0-RC2-eeepc.iso under QEMU, noting smoother performance than ARM emulators, and shared a 1.5 GB Android malware dataset (1,200+ samples, 2010–2011) from the MalGenomeProject.org for security research.  
- A proof-of-concept script was released showing that MediaFire download tokens are IP-agnostic and can be reused via distributed wget/curl calls, effectively bypassing “wait-to-download” throttling.